FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Mxbbb Umary Acid Hyaluronic Recall

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle

MXBBB · El Paso, TX

Risk level
Class II
Reported by FDA
Jan 1, 2025
Recall ID
D-0166-2025
Check your lot numberHow we source this data

Summary

Mxbbb recalled Umary Acid Hyaluronic starting Nov 14, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0166-2025 on Jan 1, 2025. Reason: cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted. Status: Ongoing.

Why it was recalled

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Product description

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

Lot numbers, UPCs & expiration codes

Lot#: 24183, Exp 07/01/28

Where it was sold

Product was sold via Amazon Marketplace.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0166-2025
Classification
Class II
Status
Ongoing
Recall initiated
Nov 14, 2024
FDA report date
Jan 1, 2025
Quantity
321 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
MXBBB

Original FDA data

Every field from FDA enforcement report D-0166-2025, exactly as published.

Show all FDA fields
City
El Paso
State
TX
Status
Ongoing
Country
United States
Event ID
95777
Address
1162 Tio Dink Cir
Code information
Lot#: 24183, Exp 07/01/28
Postal code
79907-1912
Report date
Jan 1, 2025
Product type
Drugs
Recall number
D-0166-2025
Classification
Class II
Recalling firm
MXBBB
Product quantity
321 bottles
Reason for recall
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Voluntary / mandated
Voluntary: Firm initiated
Product description
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Distribution pattern
Product was sold via Amazon Marketplace.
Recall initiation date
Nov 14, 2024
Initial firm notification
Press Release
Center classification date
Dec 26, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0166-2025, published Jan 1, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls